(Newswire.net — August 11, 2022) Orlando, FL — The rates of antibiotic resistance continue to increase around the globe. Researchers have actually been looking into the growing prevalence of this worldwide health issue.
A study has shown that in Bangladesh, antibiotic resistance is not just common but also deadly among children with pneumonia.
The research was carried out by scientists from Massachusetts General Hospital (MGH) with colleagues at the International Centre for Diarrhoeal Disease Research, Bangladesh (abbreviated as ICDDR, B).
It was published in the Open Forum Infectious Diseases journal.
The findings offer an early warning that there is an incoming pandemic of potentially deadly antibiotic resistance that may spread around the globe.
The study was spearheaded by Mohammod Jobayer Chisti, MD, Ph.D., a senior scientist in ICDDR, B’s Nutrition and Clinical Services Division.
The investigator was inspired to carry out the study upon observing that the hospital affiliated with ICDDR, B was admitting more and more young children with pneumonia. It is worth specifying that the children were highly resistant to treatment with standard antibiotics.
“At our hospital, dozens of kids died of pneumonia between 2014 and 2017, despite receiving the World Health Organization’s recommended antibiotics and enhanced respiratory support,” says Chisti.
In this study, Chisti and his colleagues looked into the health records of over 4,000 children under the age of five with pneumonia. They were admitted to their hospital between 2014 and 2017. It has been found that there was an occurring highly different pattern of bacterial infections.
“These kids are already dying early because of antibiotic-resistant bacteria, from what would be a routine infection in other parts of the world,” says Jason Harris, MD, MPH.
Harris is the co-first author of the study and chief of the division of Pediatric Global Health at the Massachusetts General Hospital for Children.
“And this was at one hospital in Bangladesh. Extrapolate these findings across a country of 163 million people, and then to a larger region where antibiotic resistance is emerging, and the overall numbers are probably huge.”
As the rates of antibiotic resistance continue to increase, researchers are increasingly carrying out studies to look into the techniques in warding it off. Some studies have shown that lessening the prevalence of UTIs, which are often treated with antibiotics, may be helpful.
It is worth keeping in mind that due to the high rates of UTIs, antibiotic misuse or overuse is widespread.
The use of all-natural remedies like D-mannose could be extremely helpful in reducing the risk of the infection (https://www.amazon.com/D-Mannose-600mg-Cranberry-Dandelion-Extract/dp/B01LX5KGF0).
About Divine Bounty
Divine Bounty is a family-owned brand that manufactures high-quality turmeric curcumin supplements. Passionate about the potential health benefits of turmeric, the team behind Divine Bounty has carefully researched and sourced only the best ingredients to create the ideal blend of turmeric curcumin. More details are available at http://www.DivineBounty.com.
Divine Bounty
12001 Research ParkwaySuite 236 A
Orlando, FL 32826
United States
4075457738
media@divinebounty.com
http://www.divinebounty.com/